UNSPSC 51373310: Acetaminophen/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373310 Acetaminophen/codeine is a Commodity code that captures state and local procurement of branded and generic opioid-acetaminophen combination pain medications, though recent state and local solicitations under or near this code show minimal direct demand for acetaminophen/codeine tablets themselves. Instead, issuing bodies are acquiring related pharmaceutical products and services: naloxone (an opioid antagonist), safe drug deactivation systems, generic multi-source pharmaceuticals through cooperative purchasing networks, and direct-to-manufacturer prescription programs. State procurement offices, county health departments, and multistate cooperative purchasing alliances drive the activity. Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) appear among the most recent solicitors, with the Texas Health and Human Services Commission issuing exploratory requests to understand direct pharmaceutical contracting models.

Recent opportunities span multiple states. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Minnesota Department of Administration's Office of State Procurement, on behalf of MMCAP, issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) seeking manufacturers of generic multi-source pharmaceuticals and OTC products for distribution through three authorized wholesalers to participating state and local government facilities in Minnesota and Oregon. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription fulfillment models for a state pharmacy benefit program. Geographic activity centers on Florida, Minnesota, Oregon, and Texas. The code shows limited direct procurement of acetaminophen/codeine tablets in recent state and local solicitations; activity instead concentrates on harm-reduction pharmaceuticals, generic drug supply agreements, and pharmacy program innovation.